These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38445489)

  • 1. Preliminary analysis of stimulation parameters for sacral neuromodulation in different indications: a multicenter retrospective cohort study from China.
    Meng L; Yan Z; Wang X; Zhang Y; Zhu Z; Zhu W; Ling Q; Sun X; Gu Y; Lv J; Li Y
    Int J Surg; 2024 Jun; 110(6):3536-3542. PubMed ID: 38445489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of sacral neuromodulation in male patients with overactive bladder, chronic pelvic pain, and fecal incontinence.
    Ferreira R; Alwashmi E; Otis-Chapados S; Bhojani N; Zorn KC; Chughtai B; Elterman DS
    Can J Urol; 2024 Aug; 31(4):11943-11949. PubMed ID: 39217518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensing in Sacral Neuromodulation: A Feasibility Study in Subjects With Urinary Incontinence and Retention.
    Goudelocke C; Jungbauer Nikolas LM; Bittner KC; Offutt SJ; Miller AE; Slopsema JP
    Neuromodulation; 2024 Feb; 27(2):392-398. PubMed ID: 37589643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urodynamic findings during the filling phase in neurogenic bladder patients with or without vesicoureteral reflux who have undergone sacral neuromodulation.
    Chen G; Liao L; Wang Y; Ying X
    Neurourol Urodyn; 2020 Jun; 39(5):1410-1416. PubMed ID: 32282088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remote programming in stage I sacral neuromodulation: a multicentre prospective feasibility study.
    Jing J; Meng L; Zhang Y; Wang X; Zhu W; Wang Q; Lu L; Song W; Zhang Y; Li Y; Ning J; Wang H
    Int J Surg; 2024 Apr; 110(4):2104-2114. PubMed ID: 38329092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Appropriate Prolonged Sacral Neuromodulation Testing in Improving Implantation Rate of a Permanent Implantable Pulse Generator in Patients with Refractory Lower Urinary Tract Dysfunctions in Mainland China.
    Zhang P; Zhang JZ; Wu LY; Zhang XD
    Chin Med J (Engl); 2017 Feb; 130(4):439-444. PubMed ID: 28218218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sacral Neuromodulation in Patients With Neurogenic Lower Urinary Tract Dysfunction: A Multicenter Retrospective Study From China.
    Masood I; Chen Q; Li J; Xu Z; Ying X; Wang Y; Chen G; Liao L
    Neuromodulation; 2021 Oct; 24(7):1278-1283. PubMed ID: 33908130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Five-Year Experience of a Retrospective, Multicenter Study in China.
    Zhang P; Wang JY; Zhang Y; Liao L; Lv JW; Ling Q; Wei ZQ; Zhong T; Xu ZH; Wen W; Li JY; Luo DY
    Neuromodulation; 2019 Aug; 22(6):730-737. PubMed ID: 30609180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of patient sex on the effectiveness of sacral neuromodulation: A cohort study from China.
    Meng L; Tian Z; Zhang W; Zhang Y; Wang J; Liao L; Ling Q; Zhang P; Wei Z; Zhong T; Xu Z; Wen W; Li J; Luo D
    Int J Surg; 2020 Dec; 84():13-17. PubMed ID: 33080412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment.
    Hoag N; Plagakis S; Pillay S; Edwards AW; Gani J
    Neurourol Urodyn; 2017 Jun; 36(5):1377-1381. PubMed ID: 27612039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of sacral neuromodulation for urinary indications. A Danish prospective study during the initial 15 months of a new service in a tertiary referral hospital.
    Kobberø H; Andersen M; Andersen K; Pedersen TB; Poulsen MH
    Scand J Urol; 2022; 56(5-6):404-411. PubMed ID: 36085579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study.
    Blok B; Van Kerrebroeck P; de Wachter S; Ruffion A; Van der Aa F; Jairam R; Perrouin-Verbe MA; Elneil S
    Neurourol Urodyn; 2019 Feb; 38(2):689-695. PubMed ID: 30592526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the Correlation Between the Clinical Effect of Sacral Neuromodulation and Patient Age: A Retrospective Multicenter Study in China.
    Meng L; Zhang W; Zhang Y; Wang J; Liao L; Chen G; Ling Q; Zhang P; Wei Z; Chen Q
    Neuromodulation; 2020 Dec; 23(8):1189-1195. PubMed ID: 32196813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Literature Review and Meta-Analysis of Sacral Neuromodulation (SNM) in Patients with Neurogenic Lower Urinary Tract Dysfunction (nLUTD): Over 20 Years' Experience and Future Directions.
    van Ophoven A; Engelberg S; Lilley H; Sievert KD
    Adv Ther; 2021 Apr; 38(4):1987-2006. PubMed ID: 33713279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sacral neuromodulation for lower urinary tract dysfunction.
    Van Kerrebroeck PE; Marcelissen TA
    World J Urol; 2012 Aug; 30(4):445-50. PubMed ID: 21989816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does sacral neuromodulation lead to relevant reduction in the need for intermittent catheterization? A single-center experience on patients with chronic urinary retention.
    Denzinger S; Nowrotek A; Weingart P; Burger M; Wieland WF; Rößler W; Otto W
    Neuromodulation; 2012; 15(6):586-91; discussion 591. PubMed ID: 22672285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device.
    Zhang Y; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J
    World J Urol; 2019 Nov; 37(11):2481-2492. PubMed ID: 30809700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium-term outcomes of sacral neuromodulation in patients with refractory overactive bladder: A retrospective single-institution study.
    Kaaki B; Gupta D
    PLoS One; 2020; 15(7):e0235961. PubMed ID: 32645082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral neuromodulation treatment for urinary voiding dysfunctions: results of treatment with the largest single-center series in a tertiary referral center in Turkey.
    Kütükoğlu MU; Altuntaş T; Şahin B; Onur AR
    Turk J Med Sci; 2023 Feb; 53(1):206-210. PubMed ID: 36945940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.